Lonza Group AG (VIE:LONN)

Austria flag Austria · Delayed Price · Currency is EUR
590.20
-0.40 (-0.07%)
At close: Dec 3, 2025
-4.74%
Market Cap 40.72B
Revenue (ttm) 7.59B
Net Income (ttm) 784.82M
Shares Out n/a
EPS (ttm) 11.10
PE Ratio 51.89
Forward PE 29.80
Dividend 4.27 (0.72%)
Ex-Dividend Date May 13, 2025
Volume n/a
Average Volume n/a
Open 592.00
Previous Close 590.60
Day's Range 588.20 - 592.00
52-Week Range 554.60 - 633.60
Beta n/a
RSI 54.79
Earnings Date Jan 28, 2026

About Lonza Group AG

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics; Small Molecules; Cell & Gene; and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substanc... [Read more]

Industry Chemicals and Allied Products
Founded 1897
Employees 18,944
Stock Exchange Vienna Stock Exchange
Ticker Symbol LONN
Full Company Profile

Financial Performance

In 2024, Lonza Group AG's revenue was 6.57 billion, a decrease of -2.13% compared to the previous year's 6.72 billion. Earnings were 636.00 million, a decrease of -2.75%.

Financial numbers in CHF Financial Statements

News

There is no news available yet.